SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-048333
Filing Date
2024-04-25
Accepted
2024-04-25 16:15:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A nmra_-_2024_proxy_-_defa.htm DEFA14A 14188
2 GRAPHIC img218924155_0.jpg GRAPHIC 108869
3 GRAPHIC img218924155_1.jpg GRAPHIC 70551
  Complete submission text file 0000950170-24-048333.txt   262620
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41802 | Film No.: 24876484
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)